Theraclion SA (TCLIF)
OTCMKTS · Delayed Price · Currency is USD
0.3200
+0.3198 (159,900.00%)
At close: Aug 26, 2024

Theraclion Statistics

Total Valuation

Theraclion has a market cap or net worth of 14.60 million. The enterprise value is 16.87 million.

Market Cap 14.60M
Enterprise Value 16.87M

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date Apr 29, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 24.11M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.52
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -2.83
EV / Sales 6.92
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 79,977
Profits Per Employee -212,866
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) -0.14
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 2,367

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Theraclion had revenue of 2.24 million and -5.96 million in losses.

Revenue 2.24M
Gross Profit 760,948
Operating Income -7.06M
Pretax Income -6.98M
Net Income -5.96M
EBITDA -6.92M
EBIT -7.06M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 33.98%, with operating and profit margins of -315.21% and -266.16%.

Gross Margin 33.98%
Operating Margin -315.21%
Pretax Margin -311.65%
Profit Margin -266.16%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Theraclion does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -40.83%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a